#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma Chronic lymphocytic leukaemia recurrent Bronchopulmonary aspergillosis Primary immunodeficiency syndrome Inborn error of metabolism Pseudoxanthoma elasticum Deafness Ureteric cancer Thromboangiitis obliterans Pulmonary alveolar haemorrhage Neuroendocrine tumour Hepato-lenticular degeneration Retinoblastoma Autoimmune demyelinating disease Sarcoidosis More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Basic Information Hereditary hypophosphataemic rickets Ewing’s sarcoma recurrent – Basic Information Glycogen storage disease type II – Life with Disease Idiopathic inflammatory myopathy – Life with Disease Vascular malformation Epidermolysis bullosa – Treatment Bronchopulmonary dysplasia Breast angiosarcoma metastatic – Treatment Myxofibrosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ammonium Chloride Bp GRNA-001 ABBV-CLS-628 Masupirdine Suvecaltamide Treprostinil Benzylpenicillin TRONTINEMAB Tigecycline Bosentan Acetylsalicylic Acid Ph. Eur. Sodium Sulfate Anhydrous Zanamivir Agrostis Stolonifera Pollen Esk-001 PEGVISOMANT Tiratricol ASP3082 VMX-C001 Disulfiram More therapies…

    Learn about Your Condition

    Hepato-lenticular degeneration Postprandial hypoglycaemia Tuberous sclerosis complex Cardiac amyloidosis Ocular lymphoma Essential thrombocythaemia Migraine with aura Hypothyroidism BRAF gene mutation Atrial septal defect Generalised anxiety disorder KBG syndrome IgA nephropathy Post-traumatic stress disorder Biliary tract disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of hydrocortisone and fludrocortisone in patients with intermediate/high-risk scheduled cardiac surgery to prevent complications

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cellulose, Microcrystalline
    • Fludrocortisone
    • Hydrocortisone
    France

  • Study on the Effects of Bexicaserin for Treating Seizures in Children and Adults with Dravet Syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Severe myoclonic epilepsy of infancy
    Belgium Czechia Denmark Finland France Germany +5

  • Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    Austria Belgium Czechia France Germany Italy +6

  • Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Croatia Czechia France Germany Ireland Italy +2

  • Study of ADCE-D01 for Patients with Metastatic or Unresectable Soft Tissue Sarcoma

    Recruiting

    2 1 1
    Investigated Drugs:
    • ADCE-D01
    Belgium France Germany

  • Study on the Effects of Empagliflozin in Patients with Euvolemic and Hypervolemic Hyponatremia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hyponatraemia
    Investigated Drugs:
    • Lactose Monohydrate
    • Empagliflozin
    Germany The Netherlands
Previous Page
1 … 220 221 222 223 224 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!